Precision medicine and data
Prenosis Sepsis ImmunoScore
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Last updated: June 5, 2026
Back to directoryConcertAI medical AI product profile
Oncology real-world data and AI platform company with products for evidence generation, clinical trials, commercial strategy, and CancerLinQ care insights.
Precision medicine and data
Best fit
Oncology sponsors, CROs, research networks, and cancer programs that need governed real-world evidence or trial intelligence built around oncology data.
- Primary use case
- Oncology-focused real-world data, generative and predictive AI, trial feasibility, trial screening, commercial insights, and care-quality analytics
- Audience
- Life sciences, oncology research, clinical operations, real-world evidence, and cancer-care quality teams
- Risk level
- High
- Pricing signal
- Enterprise oncology data, SaaS, and services pricing; request current module, dataset, and implementation terms.
- Official sources
- 3 official sources
Compare within workflow: Precision medicine and data · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating ConcertAI as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as oncology RWE, trial, and analytics infrastructure unless a specific workflow is used in patient care or a regulated submission; align each use with protocol, sponsor, IRB, and regulatory expectations. |
|---|---|
| Privacy | Review de-identification, data rights, oncology network agreements, biomarker data handling, customer-data uploads, role access, retention, and whether sponsor-facing outputs expose site or patient-level information. |
| Evidence | Validate cohort definitions, real-world data completeness, biomarker capture, model assumptions, source traceability, and study reproducibility before relying on outputs for evidence or trial decisions. |
| Workflow | Best used with oncology research, biostatistics, trial operations, privacy, and clinical governance so AI-generated insights are reviewed before trial, commercial, or quality programs change. |
Where ConcertAI fits
ConcertAI describes integrated oncology real-world data, AI innovation, and clinical expertise across real-world evidence, accelerated clinical trials, commercial solutions, CancerLinQ, and the Precision Suite, including generative AI for RWE analysis and smarter clinical-trial decisions.
Not for: Patient-specific treatment decisions, autonomous trial eligibility decisions, or regulated evidence submissions without clinical, statistical, privacy, and sponsor review.
What to verify before using ConcertAI
- Which ConcertAI product is in scope: PrecisionExplorer, PrecisionTRIALS, PrecisionGTM, Precision360, CancerLinQ, or a trial operations workflow.
- Data provenance, oncology coverage, biomarker completeness, de-identification, patient-consent posture, and permitted uses for the target project.
- How generative, predictive, or agentic AI outputs cite source data, expose uncertainty, and remain auditable for RWE, trial, or commercial decisions.
- Who confirms trial feasibility, patient-screening signals, study-design assumptions, quality measures, or oncology strategy outputs before action.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.concertai.com
- www.concertai.com / news / concertai-introduces-predictive-and-generative-ai-solutions-powered-by-multi-modal-real-world-data-key-partnerships-cara-ai-and-more-at-the-2024-asco-annual-meeting
- www.businesswire.com / news / home
Related medical AI products
Precision medicine and data
Anumana ECG-AI
Cardiovascular AI platform using standard 12-lead ECGs to surface signals such as low ejection fraction, pulmonary hypertension, and cardiac amyloidosis for clinician follow-up.
Precision medicine and data
Eko Health SENSORA
FDA-cleared cardiovascular detection platform that pairs Eko digital stethoscopes with AI-supported ECG and heart-sound analysis for supervised point-of-care screening.
Precision medicine and data
AliveCor Kardia 12L
Portable AI-powered 12-lead ECG system that uses a reduced leadset and KAI 12L algorithms to support clinician-reviewed cardiac determinations.